Mawallafi: Florence Bailey
Ranar Halitta: 24 Maris 2021
Sabuntawa: 18 Nuwamba 2024
Anonim
NTA Hausa: Jiki Da Jini Ciwon Hanta Hyperthisis
Video: NTA Hausa: Jiki Da Jini Ciwon Hanta Hyperthisis

Wadatacce

Shekara guda da ta gabata, mutane da yawa suna tunanin abin da bazara 2021 zai yi kama da farkon bala'in COVID-19. A cikin duniya bayan allurar rigakafin, taro mara rufe fuska tare da ƙaunatattu zai zama al'ada, kuma za a fara shirye-shiryen komawa ofis. Kuma na ɗan lokaci, a wasu wurare, wannan shine gaskiyar lamarin. Amma da sauri zuwa Agusta 2021, duk da haka, kuma yana jin kamar duniya ta ɗauki babban mataki na baya wajen yaƙar sabon coronavirus.

Kodayake mutane miliyan 164 a cikin Amurka an yi musu allurar rigakafin COVID-19, akwai lokuta da ba a cika samun su ba waɗanda ke da cikakkiyar alurar riga kafi za su iya ɗaukar sabon coronavirus, wanda ake kira "lambobin nasara" ta Cibiyar Kula da Cututtuka da Cututtuka. (Mai dangantaka: Catt Sadler yana rashin lafiya tare da COVID-19 Duk da an yi masa allurar riga-kafi)


Amma menene babban ci gaban kamuwa da COVID-19, daidai? Kuma yaya na kowa - kuma masu haɗari - suke? Mu nutse a ciki.

Menene Cututtukan Cigaba?

Cutar cututtuka na faruwa ne lokacin da wanda aka yi wa cikakken allurar rigakafi (kuma ya kasance aƙalla kwanaki 14) ya kamu da cutar, a cewar CDC. Wadanda ke fuskantar shari'ar nasara duk da allurar rigakafin COVID-19 na iya fuskantar ƙarancin alamun cutar ko kuma suna iya zama asymptomatic, a cewar CDC. Wasu alamomin da ke da alaƙa da ci gaban cututtukan COVID-19, kamar hancin hanci, ba su da ƙarfi fiye da sanannun alamun da ake dangantawa da COVID-19, kamar gajeriyar numfashi da wahalar numfashi, a cewar CDC.

A wannan bayanin, duk da cewa al'amuran ci gaba sun faru, adadin ci gaban da ke haifar da cututtuka masu tsanani, asibiti, ko mutuwa sun yi ƙasa sosai, a cewar Cibiyar Kiwon Lafiya ta Cleveland - kusan kashi 0.0037 ne kawai na Amurkawa da aka yi wa allurar, bisa ga lissafinsu.


Duk da cewa ba a yi la'akari da lamarin ci gaba ba, yana da kyau a lura cewa idan mutum ya kamu da COVID-19 kafin ko jim kaɗan bayan allurar rigakafi, har yanzu akwai yuwuwar za su iya kamuwa da cutar, a cewar CDC. Wannan saboda idan mutum bai sami isasshen lokaci don gina kariya daga allurar ba - wato sunadaran antibody da tsarin garkuwar jikin ku ke haifarwa, wanda ke ɗaukar kusan makonni biyu. — har yanzu suna iya yin rashin lafiya.

Shin Wannan Yana Nufin Alurar rigakafi Ba ta Aiki?

A hakikanin gaskiya, ana sa ran samun ci gaba a tsakanin alluran rigakafin. Saboda haka babu maganin rigakafi yana da tasiri dari bisa ɗari don hana rashin lafiya a cikin waɗanda aka yi wa allurar, a cewar CDC. A cikin gwaje-gwajen asibiti, an gano maganin Pfizer-BioNTech yana da tasiri kashi 95 cikin 100 wajen hana kamuwa da cuta; An gano maganin na Moderna yana da kashi 94.2 cikin 100 masu tasiri wajen hana kamuwa da cuta; kuma an gano allurar Johnson & Johnson/Janssen tana da tasiri 66.3%, duk bisa ga CDC.


Wancan ya ce, yayin da kwayar cutar ke ci gaba da rikidewa, ana iya samun sabbin nau'ikan da allurar rigakafin ba ta hana su yadda yakamata ba, kamar bambance -bambancen Delta (ƙarin kan hakan a cikin daƙiƙa ɗaya), a cewar WHO; duk da haka, maye gurbi bai kamata ya sanya allurar ta zama mara inganci ba, kuma har yanzu suna ba da kariya. (Mai alaƙa: Aiki na Pfizer A Kashi na Uku na Alurar COVID-19 Wanda 'Ƙarfi' ke Ƙarfafa Kariya)

Yaya Yawan Matsalolin Ci Gaba?

Ya zuwa ranar 28 ga Mayu, 2021, jimlar cutar COVID-19 guda 10,262 an samu rahoton a jihohi da yankuna 46 na Amurka, tare da rahoton kashi 27 cikin dari asymptomatic, a cewar bayanan CDC. Daga cikin waɗannan lamuran, kashi 10 na marasa lafiya an kwantar da su a asibiti kuma kashi 2 cikin ɗari sun mutu. Sabbin bayanan CDC (wanda aka sabunta na ƙarshe 26 ga Yuli, 2021), ya ƙidaya jimlar 6,587 da aka samu na COVID-19 inda aka kwantar da marasa lafiya a asibiti ko suka mutu, gami da mutuwar 1,263; duk da haka, ƙungiyar ba ta da tabbaci dari bisa ɗari na adadin yawan ci gaban da ake samu. Adadin cututtukan COVID-19 na ci gaba da kamuwa da cutar da aka ba da rahoto ga CDC wataƙila "ƙarancin duk cututtukan SARS-CoV-2 tsakanin" cikakken allurar, a cewar ƙungiyar. Ganin alamun kamuwa da cuta na iya rikita rikitarwa da na mura na kowa - kuma idan aka ba da gaskiyar cewa lokuta da yawa na ci gaba na iya zama asymptomatic - mutane na iya jin ba sa buƙatar yin gwaji ko neman likita.

Me yasa, daidai, ke faruwa a lokuta masu nasara? Na ɗaya, bambancin Delta yana haifar da matsala ta musamman. Wannan sabon nau'in cutar ya bayyana yana yaduwa cikin sauƙi kuma yana zuwa tare da haɗarin haɗarin asibiti, a cewar Americanungiyar Microbiology ta Amurka. Bugu da ƙari, bincike na farko ya nuna cewa alluran rigakafin mRNA (Pfizer da Moderna) suna da tasiri kashi 88 cikin ɗari ne kawai a kan alamun alamun bambancin Delta da tasirin su na kashi 93 bisa ɗari na bambancin Alpha.

Yi la'akari da wannan binciken da CDC ta fitar a watan Yuli yana ba da cikakken bayani game da barkewar COVID-19 na cutar 470 a cikin lardin Provincetown, Massachusetts: Kashi uku cikin huɗu na waɗanda suka kamu sun sami cikakkiyar allurar rigakafi, kuma an sami bambancin Delta a yawancin samfuran da aka bincika. bayanan kungiyar. Rochelle Walensky, MD, ta ce "Maɗaukakin ƙwayoyin cuta [yawan kwayar cutar da mai kamuwa da cuta zai iya samu a cikin jininsu] yana ba da shawarar ƙarin haɗarin watsawa da kuma haifar da damuwa cewa, sabanin sauran bambance-bambancen, mutanen da aka yi wa allurar rigakafin cutar ta Delta na iya yada cutar," in ji Rochelle Walensky, MD. , kuma darektan CDC, a ranar Juma'a, a cewarJaridar New York Times. Tabbas, wani binciken kasar Sin ya yi iƙirarin bambance-bambancen ƙwayar cuta ta delta ya ninka sau 1,000 fiye da nau'ikan COVID na farko, kuma mafi girman nauyin kwayar cutar, da yuwuwar wani ya yada cutar ga wasu.

Dangane da waɗannan binciken, CDC kwanan nan ta aiwatar da jagorar abin rufe fuska don cikakken allurar, yana ba da shawarar mutane su sanya su a cikin gida a wuraren da cutar ta yi yawa, tun da mutanen da aka yi wa allurar na iya yin rashin lafiya tare da yada cutar, a cewar CDC.

Abin da za ku yi idan kun yi tunanin kuna da kamuwa da cuta

Don haka, menene zai faru idan an fallasa ku ga wanda ya gwada inganci don COVID-19 amma ku da kanku an yi muku cikakken allurar rigakafi? Yana da sauki; yi gwaji. CDC ta ba da shawarar yin gwaji kwana uku zuwa biyar bayan yuwuwar kamuwa da cutar, koda kuwa ba ku da alamun cutar. A gefe guda, idan kun ji rashin lafiya - koda alamun ku masu sauƙi ne kuma kuna tsammanin mura ce kawai - yakamata ku gwada.

Kodayake COVID-19 har yanzu yana ci gaba - kuma, a, lokuta masu nasara suna yiwuwa - alluran rigakafin sun kasance manyan masu kariya don yaƙar cutar. Wancan, gami da yin tsabtar tsabtar sirri (wanke hannuwanku, rufe hancin ku da tari, zama gida idan kuna rashin lafiya, da sauransu) da bin sabunta jagororin CDC akan saka abin rufe fuska da nisantar da jama'a don kiyaye ku da sauran mutane lafiya.

Bayanai a cikin wannan labarin daidai ne har zuwa lokacin da ake bugawa. Yayin da sabuntawa game da coronavirus COVID-19 ke ci gaba da haɓaka, yana yiwuwa wasu bayanai da shawarwari a cikin wannan labarin sun canza tun farkon bugawa. Muna ƙarfafa ku da ku bincika akai-akai tare da albarkatu kamar CDC, WHO, da sashin kula da lafiyar jama'a na gida don ƙarin sabbin bayanai da shawarwari.

Bita don

Talla

Littattafai Masu Ban Sha’Awa

Man Kwakwa na Ciwan Sanyi

Man Kwakwa na Ciwan Sanyi

Man kwakwa yana ɗayan waɗancan inadarai ma u ƙarfi waɗanda aka yi amfani da u o ai a likitance t awon dubunnan hekaru. Ofaya daga cikin amfani da man kwakwa wanda ba a an hi ba hine azaman magani don ...
Yadda za a Dakatar da Farantawa Mutane (kuma Duk da haka Zama da Nishaɗi)

Yadda za a Dakatar da Farantawa Mutane (kuma Duk da haka Zama da Nishaɗi)

Faranta wa mutane rai ba zai zama kamar wannan mummunan ba ne. Bayan duk wannan, menene laifi game da kyautatawa mutane da ƙoƙarin taimaka mu u fita ko faranta mu u rai? Amma farantawa mutane gaba day...